Literature DB >> 19877629

Nitrile ylides: diastereoselective cycloadditions using chiral oxazolidinones without Lewis acid.

Mukund P Sibi1, Takahiro Soeta, Craig P Jasperse.   

Abstract

Lewis acid complexation is generally required for chiral-auxiliary-controlled stereoselectivity, and chiral Lewis acid catalysis is frequently optimal for introducing asymmetry. In this work, we show that nitrile ylide cycloadditions to electron-poor acceptors attached to chiral auxiliaries proceed in high yield and stereoselectivity in the absence of Lewis acids. In contrast, chiral Lewis acids are inferior in these cycloadditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877629     DOI: 10.1021/ol9018584

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Stereoselectivity in Oxyallyl-Furan 4+3 Cycloadditions: Control of Intermediate Conformations and Dispersive Stabilisation with Evans' Oxazolidinones.

Authors:  Elizabeth H Krenske; K N Houk; Andrew G Lohse; Jennifer E Antoline; Richard P Hsung
Journal:  Chem Sci       Date:  2010-09-01       Impact factor: 9.825

2.  A highly stereoselective Diels-Alder cycloaddition of enones with chiral cyclic 2-amidodienes derived from allenamides.

Authors:  Li-Chao Fang; Richard P Hsung; Zhi-Xiong Ma; William R Presser
Journal:  Org Lett       Date:  2013-09-03       Impact factor: 6.005

3.  Tin(iv) chloride mediated (3 + 2) annulation of trans-2-aroyl-3-styrylcyclopropane-1,1-dicarboxylates with nitriles: diastereoselective access to 5-vinyl-1-pyrroline derivatives.

Authors:  Murugesan Thangamani; Subaramaniam Thangamalar; Kannupal Srinivasan
Journal:  RSC Adv       Date:  2021-04-21       Impact factor: 3.361

4.  Novel asymmetric photodimerization reaction of coumarin derivatives bearing a chiral 2-oxazolidinone auxiliary.

Authors:  Kennosuke Itoh; Fumiya Odate; Takuma Karikomi; Keishi Obe; Tsutomu Miyamori; Hideaki Kamiya; Kenji Yoza; Kenichiro Nagai; Hideaki Fujii; Hiroyuki Suga; Ken Tokunaga
Journal:  RSC Adv       Date:  2019-04-23       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.